Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chondrosarcoma is not characterized by detectable telomerase activity.

J V Bovée1, L J van Den Broek, A M Cleton-Jansen

  • 1Department of Pathology, Leiden University Medical Center, P.O. Box 9600, L1-Q, 2300 RC Leiden, The Netherlands. J.V.M.G.Bovee@lumc.nl

The Journal of Pathology
|March 10, 2001
PubMed
Summary

Telomerase activity, crucial for cell immortality, was investigated in cartilaginous tumors. This study found telomerase was largely absent in enchondromas, osteochondromas, and chondrosarcomas, challenging its diagnostic utility.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrent MDM2 Amplification in the Spectrum of HMGA2-Altered Pleomorphic Adenoma, Atypical Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma.

Head and neck pathology·2025
Same author

Microfluidic artery-on-a-chip model with unidirectional gravity-driven flow for high-throughput applications.

Lab on a chip·2025
Same author

The Histological Composition of Capsular Contracture Focussed on the Inner Layer of the Capsule: An Intra-Donor Baker-I Versus Baker-IV Comparison.

Aesthetic plastic surgery·2018
Same author

Increased epidermal thickness and abnormal epidermal differentiation in keloid scars.

The British journal of dermatology·2016
Same author

Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasis.

Virchows Archiv : an international journal of pathology·2014
Same author

Primary intraosseous manifestation of Rosai-Dorfman disease: 2 cases and review of literature.

JBR-BTR : organe de la Societe royale belge de radiologie (SRBR) = orgaan van de Koninklijke Belgische Vereniging voor Radiologie (KBVR)·2014

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Telomerase elongates human telomeres and is reactivated in most malignant tumors, but typically absent in benign tumors.
  • Chondrosarcomas are rare malignant cartilaginous neoplasms, often difficult to distinguish histologically from benign lesions.
  • Investigating telomerase activity could aid in differentiating benign from low-grade malignant cartilaginous tumors.

Purpose of the Study:

  • To determine telomerase activity in enchondromas, osteochondromas, and chondrosarcomas.
  • To assess if telomerase reactivation correlates with chondrosarcoma progression.
  • To evaluate the diagnostic potential of the telomerase TRAP assay for cartilaginous tumors.

Main Methods:

  • The Telomeric Repeat Amplification Protocol (TRAP) assay was used to measure telomerase activity.

Related Experiment Videos

  • Samples included ten enchondromas, five osteochondromas, and 37 chondrosarcomas.
  • Tumor lysates were tested for inhibitory factors affecting telomerase detection.

    • Main Results:

    • Telomerase activity was absent in all but one tumor sample.
    • Increasing chondroid matrix correlated with increased inhibition of telomerase activity.
    • Endogenous RNAse or Taq-polymerase inhibitors were ruled out as causes of inhibition.

    Conclusions:

    • Telomerase activity is generally absent in enchondromas, osteochondromas, and chondrosarcomas.
    • The chondroid matrix may contain factors that inhibit telomerase.
    • The telomerase TRAP assay is not a reliable diagnostic tool for differentiating benign from low-grade malignant cartilaginous tumors due to lack of activity or inhibitory effects.